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ABSTRACT		
Background:	While	mortality	rates	for	cardiovascular	disease	have	declined,	many	patients	still	fail	to	
receive	effective	and	timely	care.	Studies	report	that	characteristics	including	census	region	of	the	
United	States	(Midwest,	West,	Northeast	and	South),	neighborhood	classification	(urban,	rural,	
suburban),	and	teaching	status	are	all	associated	with	the	quality	of	care	provided.	It	has	been	reported	
that	national	quality	improvement	campaigns	have	been	shown	improve	the	quality	of	AMI	care	for	
these	patients	and	increase	compliance	to	guideline	recommended	treatment.	Use	of	defect-free	
composite	measures	is	increasing	as	they	promote	full	execution	of	all	processes	of	care,	encourage	a	
focus	on	the	whole	sequence	of	care	instead	of	individual	components,	and	offer	a	more	sensitive	scale	
to	judge	improvement	in	situations	of	already	high	compliance.	The	aforementioned	hospital	
characteristics	have	not	been	analyzed	using	this	defect-free	composite	measure	as	the	outcome.	This	
study	aims	to	evaluate	the	degree	to	which	hospital	performance	varied	on	the	“all-or-none”	composite	
measure	and	to	identify	hospital	characteristics	that	were	predictive	of	higher	rates	of	defect-free	care.		
Methods:	Using	data	from	the	National	Cardiovascular	Data	Registry	(NCDR)	–	Acute	Coronary	
Treatment	and	Intervention	Outcomes	Network	(ACTION)	–	Get	With	the	Guidelines	(AR-G)	[NCDR	AR-G]	
a	total	of	791,354	patients	and	1,332	hospitals	were	analyzed.	The	“all-or-none”	defect-free	composite	
consisting	of	11	ACC/AHA	recommended	guidelines	was	the	primary	outcome.	The	association	between	
defect-free	care	and	the	hospital	characteristics	of	interest	was	determined	by	multivariate	logistic	
regression.	
Results:	Hospitals	located	in	the	Midwest	and	Northeast	regions	of	the	US	were	more	likely	to	provide	
defect-free	care	(OR	[95%	CI]:	1.79	[1.73,	1.86]	and	1.13	[1.07,	1.20],	respectively)	than	hospitals	in	the	
South;	while	hospitals	located	in	rural	or	suburban	areas	were	less	likely	(OR	[95%	CI]:	0.83	[0.80,	0.87]	
and	0.95	[0.92,	0.98])	to	provide	defect-free	care	than	hospitals	in	urban	areas.	In	addition,	teaching	
hospitals	are	less	likely	to	provide	defect-free	care	(OR	[95%	CI]:	0.96	[0.93,	0.99])	than	hospitals	that	are	
non-teaching.	Hospitals	in	all	categories	demonstrated	positive	trends	in	compliance	throughout	the	
study	period.	
Conclusions:	In	order	to	move	from	already	high	rates	of	compliance	to	full	compliance,	it	must	be	
recognized	that	hospital	level	variations	in	care	still	exist.	This	continued	variation	in	care	by	hospital	
characteristics	suggests	that	the	institutions	within	each	category	face	unique	challenges.	Studies	are	
needed	to	identify	these	challenges	and	propose	potential	solutions.	
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Hospital	Variation	in	Performance	for	Acute	Myocardial	Infarction	with	the	NCDR	ACTION	Registry-
GWTG	"All-or-None”	Composite	Measure	
BACKGROUND	
Cardiovascular	disease	remains	the	leading	cause	of	mortality	in	the	US.	While	mortality	rates	have	
declined,	many	patients	still	fail	to	receive	effective	and	timely	care	[1].	National	quality	improvement	
campaigns	have	been	implemented	in	an	effort	to	improve	care	for	individuals	with	the	disease	and	to	
reduce	morbidity	and	mortality	[2].	These	quality	improvement	campaigns	utilize	evidence	based	
performance	indicators,	including	process	of	care	measures,	to	reflect	the	quality	of	care	at	each	
institution	[3].	Quality	of	care	is	assessed	based	upon	performance	on	the	recommendations	
individually,	or	by	performance	on	composite	measures	[4].	
The	defect-free	composite	outcome	is	an	“all-or-none”	summary	measure.	The	measure	contains	
the	aforementioned	treatment	recommendations	for	AMI	care	such	as	pharmacotherapy,	timely	
reperfusion	and	referral	to	cardiac	rehabilitation	programs	[5].	This	measure	presents	information	
different	from	that	of	an	item-by-item	approach	as	it	describes	overall	quality	of	care	and	adherence	to	
guidelines	and	promotes	a	high	standard	of	excellence	[4-5].	The	use	of	the	defect-free	composite	
measure	is	increasing	because	it	promotes	full	execution	of	all	processes	of	care,	encourages	a	focus	on	
the	whole	sequence	of	care	instead	of	individual	components,	and	offers	a	more	sensitive	scale	to	judge	
improvement	in	situations	of	already	high	compliance	[4].	Additionally,	studies	have	found	an	inverse	
association	between	composite	compliance	and	in	hospital	mortality	[3,7].		
Studies	report	that	characteristics	including	census	region	of	the	United	States	(Midwest,	West,	
Northeast	and	South),	neighborhood	classification	(urban,	rural,	suburban),	and	teaching	status	are	all	
associated	with	quality	of	care	provided,	with	higher	compliance	to	guideline	recommended	care	in	the	
northeast,	urban	hospitals	and	teaching	hospitals	[8-13].	Previous	studies	have	identified	that	the	
campaigns	have	been	shown	to	improve	the	quality	of	care	for	patients	with	coronary	artery	disease	
(CAD)	[14-15]	and	investigators	have	reported	positive	trends	in	adherence	to	individual	process	of	care	
measures	[16].	However,	the	aforementioned	hospital	characteristics	have	not	been	analyzed	using	the	
defect-free	composite	measure	as	the	outcome.		
Therefore,	using	data	from	the	National	Cardiovascular	Data	Registry	(NCDR)	–	Acute	Coronary	
Treatment	and	Intervention	Outcomes	Network	(ACTION)	–	Get	With	the	Guidelines	(AR-G)	[NCDR	AR-
G],	this	study	examines	the	association	between	teaching	status,	census	region	of	the	US	and	
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neighborhood	classification	of	hospitals	and	use	of	defect-free	care	in	order	to	evaluate	the	degree	to	
which	hospital	performance	varied	on	the	“all-or-none”	composite	measure	and	to	identify	hospital	
characteristics	that	were	predictive	of	higher	rates	of	defect-free	care.		
METHODS	
NCDR	ACTION	Registry	Get	With	the	Guidelines	(NCDR	AR-G)	
NCDR	ACTION	Registry	Get	With	the	Guidelines	Program	was	launched	in	2007	through	a	merger	of	
the	American	College	of	Cardiology’s	(ACC)	ACTION	with	the	National	Registry	of	Myocardial	Infarction	
and	Can	Rapid	risk	stratification	of	Unstable	angina	patients	Suppress	ADverse	outcomes	with	Early	
(CRUSADE)	of	the	ACC/American	Heart	Association	(AHA).	A	year	later	the	registry	again	merged	with	
the	AHA’s	GWTG-Coronary	Artery	Disease	Program	[17].	The	final	registry	represents	a	unified	effort	to	
assess	the	characteristics	and	outcomes	of	patients	with	AMI	and	utilize	evidence	based	treatment	
methods	to	improve	national	acute	myocardial	infarction	care	and	improve	patient	outcomes	[5].	
The	methods	of	the	NCDR	AR-G	have	been	described	previously	[5].	Briefly,	all	data	elements	are	
abstracted	via	chart	review	of	participating	hospitals	and	submitted	via	a	secure,	password-protected,	
web	based	server	programmed	to	optimize	data	quality	at	the	time	of	entry.	The	collected	data	
elements	were	selected	by	the	AR-G	Steering	Committee	and	chosen	to	maximize	quality	improvement	
efforts.	They	are	composed	of	the	core	set	of	ACC/AHA	Performance	Measures	and	Class	I	
Recommendations	of	the	ACC/AHA	clinical	practice	guidelines	[18].	These	two	sets	of	practice	guidelines	
are	used	as	definitions	of	performance	and	quality	metrics	and	are	presented	in	quarterly	benchmarked	
reports	to	participating	hospitals	[17].	In	addition	to	performance	measures	and	clinical	practice	
guidelines,	patient	demographics,	presenting	features,	prehospital	therapy,	in-hospital	therapy,	hospital	
discharge	therapy,	timing	of	care	delivery,	laboratory	tests,	procedures,	and	patient	outcomes	are	
collected	[5].	The	ACC/AHA	Performance	Measures,	as	well	as	examples	of	additional	ACTION	AR-G	data	
elements	are	presented	in	Tables	1	and	2	in	the	Appendix.	Data	elements	are	abstracted	by	trained	
personnel	via	chart	review	and	entered	into	a	secure,	password-protected,	web-based,	server	system	
[5].	
The	AR-G	includes	patients	with	a	primary	diagnosed	of	STEMI	or	NSTEMI	as	defined	by	(1)	ischemic	
symptoms	at	rest,	lasting	≥	10	minutes,	occurring	within	24	hours	before	admission	or	up	to	72	hours	for	
STEMI;	(2)	ECG	changes	associated	with	STEMI	(new	left	bundle-branch	block	[LBBB]	or	persistent	ST	
segment	elevation	≥	1	mm	in	2	or	more	contiguous	electrocardiographic	leads);	or	(3)	positive	cardiac	
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markers	associated	with	NSTEMI	(CK-MB	or	Troponin	I/T	>	local	laboratory	upper	limit	of	normal	values)	
within	24	hours	after	initial	presentation.	Transfer	patients	meeting	these	criteria	must	arrive	at	the	
participating	hospital	within	72	hours	of	the	time	of	initial	presentation	to	the	outside	hospital.	Patients	
are	ineligible	for	the	AR-G	if	ischemic	symptoms	are	developed	during	the	hospital	stay,	but	originally	
presented	with	symptoms	unrelated	to	STEMI	or	NSTEMI.	Cases	are	identified	retrospectively	through	
chart	review	[5].		
Exclusion	Criteria	
This	analysis	includes	all	eligible	adults	(age	≥	18)	cared	for	at	hospitals	in	the	registry	between	
January	1,	2010	and	December	31,	2014.	Since	previous	research	has	shown	that	participation	in	GWTG	
is	independently	associated	with	improvements	in	guideline	adherence,	the	study	cohort	was	further	
limited	to	hospitals	that	continuously	participated	in	the	registry	during	the	study	period	[19].		
Continuous	participation	was	defined	as	a	minimum	of	50	cases	per	year	during	the	study	period	to	
ensure	adequate	sample	size	to	estimate	hospital	performance.	The	institutional	review	board	for	the	
AR-G	Analytic	Center	located	at	the	Duke	Clinical	Research	Institute	approved	use	of	this	data.	
“All-or-None”	Defect-Free	Composite	Measure		
An	evidence	based	composite	quality	measure	was	used	to	describe	quality	of	care	by	hospital	
characteristics.	This	composite	score	is	composed	of	the	following	for	the	STEMI	population:	
(1)	Aspirin	at	Arrival,	(2)	Aspirin	prescribed	at	Discharge,	(3)	Beta-Blocker	Prescribed	at	Discharge,	(4)	
Statin	Prescribed	at	Discharge,	(5)	Evaluation	of	LV	Systolic	Function,	(6)	ACEI	or	ARB	for	LVSD	at	
Discharge,	(7)	Time	to	Fibrinolytic	Therapy,	(8)	Time	to	Primary	PCI,	(9)	Reperfusion	Therapy,	(10)	Adult	
Smoking	Cessation	Advice	Counseling,	and	(11)	Cardiac	Rehabilitation	Patient	Referral	From	an	Inpatient	
Setting;	and	for	the	NSTEMI	population:	(1)	Aspirin	at	Arrival,	(2)	Aspirin	prescribed	at	Discharge,	(3)	
Beta-Blocker	Prescribed	at	Discharge,	(4)	Statin	Prescribed	at	Discharge,	(5)	Evaluation	of	LV	Systolic	
Function,	(6)	ACEI	or	ARB	for	LVSD	at	Discharge,	(7)	Adult	Smoking	Cessation	Advice	Counseling,	and	(8)	
Cardiac	Rehabilitation	Patient	Referral	From	an	Inpatient	Setting.	A	list	of	the	aforementioned	
performance	indicators	and	their	definitions	is	presented	in	Table	3	of	the	Appendix.	The	defect-free	
care	measure	was	achieved	if	the	patient	received	all	interventions	in	which	they	were	eligible.		
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Statistical	Analysis	
The	association	between	defect-free	care	and	the	hospital	characteristics	of	interest:	census	region	
of	the	United	States,	neighborhood	classification,	and	teaching	status	was	determined	by	logistic	
regression.	The	census	region	variable	was	characterized	as	either	Northeast,	Midwest,	South	or	West,	
according	to	the	US	Census	Bureau	definition	(Northeast	included	Connecticut,	Maine,	Massachusetts,	
New	Hampshire,	Rhode	Island,	Vermont,	New	Jersey,	New	York	and	Pennsylvania;	Midwest	included	
Indiana,	Illinois,	Michigan,	Ohio,	Wisconsin,	Iowa,	Kansas,	Minnesota,	Missouri,	Nebraska,	North	Dakota	
and	South	Dakota;	South	included	Delaware,	District	of	Colombia,	Florida,	Georgia,	Maryland,	North	
Carolina,	South	Carolina,	Virginia,	West	Virginia,	Alabama,	Kentucky,	Mississippi,	Tennessee,	Arkansas,	
Oklahoma	and	Texas;	West	included	Arizona,	Colorado,	Idaho,	New	Mexico,	Montana,	Utah,	Nevada,	
Wyoming,	Alaska,	California,	Hawaii,	Oregon	and	Washington).		Neighborhood	classification	was	
determined	by	location	of	the	hospital	and	defined	as	being	in	either	a	rural,	urban	or	suburban	
community.	Teaching	status	was	determined	by	the	hospital’s	academic	status.		
An	unadjusted,	bivariate	model	was	run	for	each	characteristic	independently.	A	multivariate	logistic	
regression	was	then	performed.	This	model	included	all	aforementioned	characteristics	along	with	
additional	patient	and	hospital	characteristics	that	were	identified	as	significant	through	prior	literature	
review.	The	patient-level	covariates	included	in	each	model	were	age,	sex,	race,	cocaine	use,	presenting	
heart	rate,	initial	ECG	findings,	troponin	ratio	and	creatinine	clearance	upon	presentation,	smoking	
status,	previous	diagnosis	of	lung	disease,	diabetes,	coronary	artery	disease,	heart	failure	and	atrial	
fibrillation,	as	well	as	prior	percutaneous	coronary	intervention	or	coronary	artery	bypass	grafting.	Age	
was	divided	into	4	categories:	age	<	55,	55-64,	65-74,	>=	75;	race	was	defined	as	white,	black,	Hispanic	
or	other,	and	initial	ECG	findings	were	either	ST	elevation,	left	bundle	branch	block	(LBBB),	or	isolated	
posterior	MI.	Troponin	ration	was	calculated	as	the	initial	troponin	value	(upon	presentation)	over	the	
initial	troponin	URL,	while	creatinine	clearance	was	calculated	using	the	following	formula:	(140-
age)*weight*(0.85	for	female	or	1	for	male)/(72*(initial	Creatinine	Value)).	Coronary	artery	disease	was	
defined	as	prior	incidence	of	MI,	PCI,	or	CABG.		
Additional	hospital	characteristics	of	interest	include	bed	size,	hospital	type	(government,	
community,	or	university),	annual	number	of	cardiac	catheterizations,	annual	number	of	percutaneous	
coronary	interventions,	public/private	classification,	and	percentage	of	the	hospital’s	patient	volume	
covered	by	Medicare.	Bed	size,	annual	number	of	cardiac	caths,	annual	number	of	PCIs,	and	percentage	
of	Medicare	patients	were	divided	into	quartiles.	The	quartile	divisions	are	as	follows:	bed	size:		
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Q1=0-258,	Q2=259-389,	Q3=390-572,	Q4=573-2,000;	annual	number	of	cardiac	caths:	Q1=0-850,	
Q2=851-1,499;	Q3=1,500-2,562;	Q4=2,563-13,500;	annual	number	of	PCIs:	Q1=0-357,	Q2=358-675,	
Q3=676-1,129,	Q4=1,130-4,722;	and	finally	percentage	of	Medicare	patients:	Q1=0-42%,	Q2=43-52%,	
Q3=53-60%,	Q4=61-100%.	Descriptive	statistics	for	variables	in	the	multivariate	model	can	be	found	in	
Tables	4	and	5	in	the	appendix.	All	p-values	were	compared	to	a	two-sided	alpha	level	of	0.05.	
The	analyses	for	Tables	1	consisted	of	calculating	frequencies	for	categorical	variables	and	the	
median	and	interquartile	range	for	continuous	variables,	stratified	by	hospital	characteristic.		The	
analysis	for	Table	2	consisted	of	calculating	the	median	and	interquartile	range	for	the	defect-free	care	
variable,	stratified	by	year.		
Data	was	analyzed	using	SAS	version	9.3.	
RESULTS	
A	total	of	791,354	patients	were	admitted	to	1,332	hospitals	during	the	study	period.	After	
excluding	cases	that	did	not	meet	the	quality	check	(n=136,811	patients;	494	hospitals),	non-adults	
(n=144	patients;	5	hospitals),	cases	outside	the	study	period	(n=134,279	patients;	80	hospitals),	
hospitals	with	less	than	50	cases	per	year	throughout	study	period	(n=157,295	patients,	458	hospitals)	
and	patients	not	eligible	for	defect-free	care	(n=41,996	patients,	25	hospitals)	the	final	cohort	contained	
320,829	individuals	and	270	hospitals.	Key	characteristics	and	patient	demographics	within	each	hospital	
category	are	presented	in	Table	1.		
Number	of	individuals	varied	by	region	of	the	US,	with	the	highest	representation	from	the	South	
with	191,271	individuals,	followed	by	105,724	individuals	from	the	Midwest,	44,787	individuals	from	the	
West	and	25,672	individuals	from	the	South.	The	median	age	between	the	regions	are	similar	(63-65	
years);	however,	the	regions	vary	by	sex	and	race.	The	Northeast	had	the	highest	representation	of	
females	(36.95%),	followed	by	the	Midwest	(34.79%)	and	the	South	(34.41%),	and	finally	the	West	
(32.27%).	The	West	had	the	highest	percentage	of	Hispanics	(9.55%),	followed	by	the	South	(4.64%),	
then	the	Northeast	(3.81%)	and	the	Midwest	(2.84).	Distribution	of	whites	also	varied	by	US	region.	The	
population	from	Northeast	was	composed	of	90.32%	white	individuals,	followed	by	the	Midwest	and	the	
West	with	89.57%	and	89.31%	white	individuals,	respectively,	and	lastly	the	South	with	80.38%	white	
individuals.	The	highest	percent	of	black	individuals	was	found	in	the	South	(16.94	%),	followed	by	the	
Midwest	(8.24%),	the	Northeast	(6.85),	and	the	West	(3.66),	while	5.29%	of	the	West,	2.26%	of	the	
Northeast,	2.11%	of	the	South	and	1.86%	of	the	Midwest	are	composed	of	individuals	of	other	
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ethnicities.	Among	the	study	cohort	39.72%	of	individuals	from	the	West	presented	with	STEMI,	
followed	by	39.40%	in	the	South,	37.86%	in	the	Northeast	and	36.52%	in	the	Midwest.	The	South	had	
the	highest	rates	of	smokers	(36.77%)	followed	by	the	Midwest	(35.94%),	the	Northeast	(30.25%)	and	
the	West	(29.73%).		
Number	of	patients	again	varied	by	community	location;	212,246	individuals	were	from	an	urban	
hospital,	51,292	were	from	a	rural	hospital,	and	103,916	were	from	a	suburban	hospital.	Median	age	
was	similar	between	community	locations	(63-64	years)	as	was	percent	female	(approx.	34%).	However,	
like	region	of	the	US,	race	varied	across	types	of	communities.	Urban	hospitals	had	the	highest	
percentage	of	Hispanic	individuals	(5.02%),	followed	by	suburban	hospitals	(4.98%),	then	rural	hospitals	
(2.51%).	The	highest	percentage	of	whites	was	found	at	rural	hospitals	(89.55%),	followed	by	suburban	
hospitals	(85.02%),	then	urban	hospitals	(83.56%).	Urban	hospitals	were	composed	of	13.61%	blacks,	
while	the	suburban	and	rural	hospitals	were	composed	of	10.84%	and	8.51%,	respectively.	Other	
ethnicities	had	the	highest	representation	in	suburban	hospitals	(3.41%),	followed	by	urban	hospitals	
(2.13%),	and	finally	rural	hospitals	(1.73%).	Smoking	status	varied	slightly	between	community	locations.	
Rural	hospitals	were	composed	of	37.75%	smokers,	followed	by	36.64%	in	urban	hospitals,	and	31.06%	
in	suburban	hospitals.		
Among	patients	in	the	cohort,	176,945	were	treated	at	a	teaching	hospital	and	190,479	were	
treated	at	a	non-teaching	hospital.	Proportion	of	females	was	similar	between	hospital	types	
(approximately	34%);	median	age	was	also	similar	(63-64	years).	Race	varied	with	non-teaching	hospitals	
having	87.14%	whites	as	opposed	to	82.64%	in	teaching	hospitals.	Teaching	hospitals	had	a	higher	
percentage	of	blacks	(14.42%)	but	a	lower	percentage	of	Hispanics	(3.97%)	as	compared	to	non-teaching	
hospitals	(9.63%	and	5.41%,	respectively).	Percentage	of	other	ethnicity	was	similar	(approximately	2%).	
Clinical	presentation	and	risk	factors	were	similar	within	all	characteristics.	Heart	rate	ranged	from	
80-82	bpm	and	BMI	ranged	from	28.4	to	29.	Hypertension	was	present	in	approximately	70-75%	of	
individuals;	diabetes	was	present	in	approximately	30-34%	of	individuals.	Approximately	32-38%	had	a	
history	of	coronary	artery	disease,	21-25%	had	a	history	of	MI,	10-12%	had	a	history	of	cerebrovascular	
disease,	10-12%	had	a	history	of	heart	failure	and	6-8%	had	a	history	of	stroke.	Approximately	21-25%	
had	undergone	a	previous	PCI	and	11-14%	had	undergone	a	previous	CABG.	
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Total	Patients: 105724 44787 25672 191271 212246 51292 103916 176975 190479
Demographics
Age	(y):	 64.00	(55.00,	75.00)	 65.00	(56.00,	75.00) 65.00	(55.00,	77.00) 63.00	(54.00,	73.00) 63.00	(54.00,	74.00) 64.00	(54.00,	74.00) 64.00	(55.00,	75.00) 64.00	(55.00,	74.00) 63.00	(54.00,	74.00)
Female 34.79 32.27 36.95 34.41 34.12 34.51 34.91 34.32 34.48
Race
Hispanic 2.84 9.55 3.81 4.64 5.02 2.51 4.98 3.97 5.41
White	non-hispanic 89.57 89.31 90.32 80.38 83.56 89.55 85.02 82.64 87.14
Black	non-Hispanic 8.24 3.66 6.85 16.94 13.61 8.51 10.84 14.42 9.63
Other 1.86 5.29 2.26 2.11 2.13 1.73 3.41 2.27 2.62
Clinical	features	on	presentation
Heart	Rate	(beat/min) 82.00	(69.00,	97.00) 80.00	(68.00,	95.00) 82.00	(70.00,	97.00) 82.00	(69.00,	97.00) 81.00	(69.00,	96.00) 82.00	(69.00,	97.00) 82.00	(69.00,	97.00) 82.00	(69.00,	97.00) 82.00	(69.00,	96.00)
STEMI 36.52 39.72 37.86 39.4 39.91 35.86 36.94 38.17 38.86
History	and	Risk	Factors
BMI 29.00	(25.50,	33.40) 28.10	(24.80,	32.20) 28.40	(25.10,	36.20) 28.50	(25.10,	32.80) 28.70	(25.10,	33.00) 28.70	(25.20,	33.00) 28.40	(25.10,	32.70) 28.50	(25.10,	32.90) 28.7	(25.10,	32.90)
Current/Recent	Smoker	(w/in	1	year) 35.94 29.73 30.25 36.77 36.64 37.75 31.06 35.98 34.40
Hypertension 73.35 70.27 72.87 75.41 73.94 74.93 73.72 74.83 73.14
Diabetes	Mellitus 32.32 30.58 30.88 34.44 33.37 33.72 32.28 33.4 32.80
Prior	CAD 36.14 32.48 32.46 37.86 36.18 38.42 35.62 36.77 35.86
Prior	MI 24.18 22.59 21.49 25.81 24.95 25.83 23.45 25.55 23.68
Prior	PCI 25.04 21.69 20.92 25.53 24.59 25.83 24 24.66 24.54
Prior	CABG 13.63 10.93 12.59 14.06 12.99 15.29 13.47 13.6 13.29
Prior	Heart	Failure 11.84 9.99 9.88 12.27 11.55 12.66 11.53 12.38 10.97
Cerebrovascular	Disease 12.25 10.94 10.43 12.27 12.09 12.36 11.54 12.43 11.48
Prior	Stroke 7.46 6.83 6.41 8.16 7.68 7.97 7.52 7.88 7.46
**Continuous	variables	are	presentes	as	Median	(Q1,	Q3)
Table	1:	Selected	Patient	Characteristics	by	Hospital	Characteristic
Rural Suburban Teaching Non-Teaching
*Categorical	variables	are	presented	as	percentages
Region	of	the	US Community	Location Teaching	Status
Description Midwest West Northeast South Urban
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Table	2	presents	use	of	the	defect-free	care	measure	among	hospital	groups,	stratified	by	year.	
Hospitals	in	the	Northeast	had	higher	rates	of	compliance	than	its	counterparts;	however,	hospitals	
within	each	region	demonstrated	increasing	use	of	defect-free	measure	indicating	increasing	
compliance.	Teaching	hospitals	started	at	a	higher	rate	of	use	of	defect-free	care,	however	this	gap	
closed	as	compliance	increased	in	both	groups	throughout	the	study	period.	Urban	and	suburban	
hospitals	demonstrated	similar	rates	of	defect-free	care	throughout	the	study	period,	starting	at	higher	
levels	of	compliance	when	compared	to	rural	hospitals.	While	there	were	positive	trends	among	all	
hospitals	in	this	category,	gaps	between	urban/suburban	and	rural	hospitals	persist.		
		
The	results	of	the	logistic	regression	analyses	are	found	in	Table	3.	In	the	adjusted	analyses,	
hospitals	located	in	the	Midwest	and	Northeast	regions	of	the	US	were	more	likely	to	provide	defect-
free	care	(OR	[95%	CI]:	1.79	[1.73,	1.86]	and	1.13	[1.07,	1.20],	respectively)	than	hospitals	in	the	South;	
while	hospitals	located	in	rural	or	suburban	areas	were	less	likely	(OR	[95%	CI]:	0.83	[0.80,	0.87]	and	
0.95	[0.92,	0.98])	to	provide	defect-free	care	than	hospitals	in	urban	areas.	.	In	addition,	teaching	
hospitals	are	less	likely	to	provide	defect-free	care	(OR	[95%	CI]:	0.96	[0.93,	0.99])	than	hospitals	that	are	
non-teaching.	
Description N 2010 2011 2012 2013 2014
Total 270 67.0	(47.1,	80.6) 74.2	(56.9,	83.7) 75.8	(62.6,	85.7) 78.1	(68.0,	86.1) 79.7	(67.8,	86.6)
Region
Northeast 16 75.4	(62.4,	84.4) 78.8	(70.0,	87.8) 81.6	(72.7,	89.2) 81.2	(73.5,	88.3) 81.3	(72.2,	88.6)
Midwest 83 56.7	(45.8,	79.6) 67.9	(46.8,	81.7) 73.0	(62.2,	81.1) 77.4	(70.4,	86.4) 82.3	(71.0,	86.3)
South 133 62.0	(40.0,	75.9) 68.8	(50.0,	82.3)	 74.1	(58.0,	82.6) 76.9	(65.4,	85.1) 78.4	(66.7,	85.6)
West 38 62.2	(38.9,	80.7) 70.7	(50.0,	82.7) 73.3	(45.5,	81.9) 74.1	(54.3,	83.7) 77.7	(62.1,	85.7)
Teaching	status
No 154 66.3	(44.6,	80.1) 75.1	(56.0,	83.9) 75.8	(59.4,	85.7) 79.1	(68.0,	85.6) 80.0	(67.9,	86.6)
Yes 116 68.0	(50.3,	81.0) 70.9	(57.4,	83.2) 75.9	(67.6,	85.7) 77.2	(68.2,	86.5) 79.3	(67.4,	86.3)
Community
Urban 147 67.9	(45.9,	81.0) 74.2	(57.9,	84.6) 75.6	(62.6,	84.9) 77.6	(67.4,	85.8) 80.0	(67.5,	85.7)
Rural 43 62.9	(51.5,	75.4) 70.5	(56.0,	83.9) 73.5	(58.3,	84.3) 77.5	(63.9,	84.4) 75.2	(63.3,	89.6)
Suburban 80 67.1	(41.3,	81.6) 75.6	(55.7,	83.5) 77.3	(65.4,	86.9) 80.3	(68.5,	87.3) 79.5	(68.9,	87.2)
Table	2:	Use	of	The	Defect-Free	Care	Measure	Among	Hospital	Groups
	Median	(Q1,	Q3)
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DISCUSSION	
Previous	work	utilizing	data	from	the	National	Cardiovascular	Data	Registry	(NCDR)	–	Acute	
Coronary	Treatment	and	Intervention	Outcomes	Network	(ACTION)	–	Get	With	the	Guidelines	(AR-G)	
program	shows	improving	quality	of	AMI	care	over	time	[14-15].	In	order	to	focus	on	overall	quality	of	
care	and	to	examine	improvement	in	situations	of	already	high	compliance,	a	defect	free	“all-or-none”	
composite	measure	is	utilized.	The	findings	of	this	study	suggest	that	each	of	the	characteristics	of	
interest:	census	region	of	the	US,	and	neighborhood	classification,	and	teaching	status,	are	significantly	
associated	with	providing	defect-free	care.		
These	significant	findings	imply	that	while	quality	of	care	has	improved	since	the	inception	of	
national	quality	improvement	programs,	significant	variations	in	performance	and	gaps	in	care	remain.	
Additionally,	the	use	of	the	defect-free	composite	measure	highlights	the	opportunity	for	improvement	
in	both	quality	of	care	and	patient	outcomes,	as	studies	have	shown	an	inverse	relationship	between	
composite	adherence	and	in-hospital	mortality	[3,7].		
Results	from	previous	studies	examining	the	association	between	regional	variation	and	quality	of	
care	are	conflicting.	While	some	have	found	significant	regional	variation	[10-11],	a	study	by	Laskey	and	
colleagues	utilizing	GWTG-CAD	data	from	2000-2008	found	no	significant	difference	in	use	of	defect-free	
care	by	region	[20].	However,	since	this	study,	the	guidelines	have	been	expanded	from	6	measures	to	
the	current	11	for	STEMI	or	9	for	NSTEMI.	This	suggests	the	possibility	of	undetected	variation	by	one	of	
the	newer	measures.	
Region	of	US:
Midwest 65.7	(63.5,	77.4) 0.44 ± 0.01 1.55 1.53 1.58 <.0001 0.58 ± 0.02 1.79 1.73 1.86 <.0001
Northeast 78.3	(71.8,	86.4) 0.10 ± 0.02 1.11 1.07 1.14 <.0001 0.12 ± 0.03 1.13 1.07 1.20 <.0001
West 72.3	(52.5,	81.4) -0.13 ± 0.01 0.88 0.86 0.90 <.0001 -0.05 ± 0.02 0.95 0.91 0.99 0.026
South 72.3	(56.7,	80.4) -- -- -- --
Hospital	Location:
Rural 72.8	(56.8,	80.2) -0.06 ± 0.00 0.94 0.92 0.96 <.0001 -0.18 ± 0.02 0.83 0.80 0.87 <.0001
Suburban 75.0	(61.2,	84.2) -0.07 ± 0.01 0.94 0.92 0.95 <.0001 -0.05 ± 0.02 0.95 0.92 0.98 0.001
Urban 75.1	(59.6,	82.2) -- -- -- --
Teaching	Status:
Teaching 74.4	(61.2,	81.8) 0.87 ± 0.01 1.19 1.17 1.21 <.0001 -0.04 ± 0.02 0.96 0.93 0.99 0.010
Non-Teaching 75.3	(57.9,	82.4) -- -- -- --
Table	3:	Unajusted	and	Adjusted	associations	between	defect-free	care	and	hospital	characteristics.
UNADJUSTED	LOGISTIC	REGRESSIONa ADJUSTED	LOGISTIC	REGRESSION
Characteristic
ESTIMATE	±	SE ODDS	RATIO 95%	CI P	VALUE ESTIMATE	±	SE ODDS	RATIO
aAll	p	values	are	compared	to	a	two-sided	0.05	significance	level	(p<0.05).	All	significant	p	values	are	bolded.	
DEFECT-FREE	CARE	USE	
Median	(Q1,	Q3)
REFERENCE -- REFERENCE --
REFERENCE -- REFERENCE --
95%	CI P	VALUEa
REFERENCE -- REFERENCE --
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Studies	examining	urban/rural	status	and	quality	of	care	have	also	presented	conflicting	results.	A	
study	performed	by	Ambardekar	and	colleagues	examining	individuals	in	the	GWTG-CAD	program	from	
2000-2008	found	no	independent	association	between	rural	status	and	lower	compliance	to	
performance	measures	[21].		However,	a	study	done	by	Baldwin	and	colleagues	examining	Medicare	
beneficiaries	from	2000-2001	found	that	patients	admitted	to	small,	rural	hospitals	were	significantly	
less	likely	to	receive	guideline-recommended	treatment.	Additionally,	the	study	found	no	difference	in	
quality	of	care	between	large	rural	hospitals	and	urban	hospitals	[13].	The	findings	of	this	study	differ	
from	this	previous	research,	as	it	was	determined	that	hospitals	located	in	a	rural	setting	are	
significantly	less	likely	to	provide	defect-free	care.	In	the	study	performed	by	Ambardekar	et	al.,	
association	was	determined	with	each	performance	measure	independently,	and	high	rates	of	
compliance	were	observed	[21].		Thus,	a	potential	explanation	for	the	difference	in	findings	is	the	
presence	of	a	“ceiling	effect.”	By	choosing	the	defect-free	composite	as	the	outcome	of	interest,	this	
study	was	able	to	gain	an	understanding	of	the	overall	quality	of	care	and	was	more	sensitive	to	
difference	in	adherence	to	guidelines	that	may	have	not	been	evident	because	of	high	compliance	to	
individual	measures.		
The	study’s	findings	on	the	association	between	teaching	hospitals	and	lower	quality	care	differ	
from	previous	studies	that	have	found	an	association	between	teaching	hospitals	and	higher	quality	of	
care	[8,12].	While	the	difference	in	findings	could	be	a	result	of	random	variation,	another	explanation	
could	be	the	nature	of	the	composite	outcome.	It	is	possible	that	teaching	hospitals	perform	well	when	
considering	the	guidelines	independently,	but	have	lower	rates	of	achieving	the	composite	outcome	
because	of	its	“all-or-none”	nature.		For	example,	a	teaching	hospital	may	comply	with	the	first	10	of	the	
composite	measure	components	99%	of	the	time,	but	only	give	cardiac	rehabilitation	referrals	75%	of	
the	time.	When	measuring	compliance	by	individual	components	this	hospital	would	be	considered	to	
have	a	high	level	of	compliance.	However,	when	measuring	compliance	with	the	defect-free	composite,	
this	hospital’s	compliance	is	dependent	upon	providing	cardiac	rehabilitation	referrals.	Additionally,	a	
study	performed	by	Patel	et	al.	that	examined	compliance	using	a	composite	outcome	found	high	rates	
of	variation	among	individual	centers	in	these	categories,	with	higher	variation	among	non-teaching	
hospitals.	In	fact,	15	of	the	20	highest	performing	sites	and	19	of	the	20	lowest	performing	sites	were	
non-teaching	hospitals	[9].		
The	findings	of	the	present	study	add	to	the	evidence	that	variations	exist	by	hospital	
characteristics.	Previous	studies	proved	that	variations	in	care	are	present	when	considering	
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characteristics	of	the	patient	such	as	race	or	sex	[22].	As	a	result,	quality	improvement	efforts	began	
emphasizing	and	targeting	these	gaps.	Like	the	earlier	studies,	the	findings	of	this	study	highlight	gaps	at	
the	hospital	level	and	indicate	that	these	should	qualities	be	taken	into	account	when	pursuing	quality	
improvement.	Continued	variation	in	care	by	hospital	characteristics	suggests	that	the	institutions	
within	each	category	face	unique	challenges.	For	example,	the	expanded	chain	of	command	in	teaching	
hospitals	may	hinder	timely	administration	of	medications.	In	order	to	take	the	next	step	and	move	from	
already	high	rates	of	compliance	to	full	compliance,	it	must	be	recognized	that	hospital	level	variations	
in	care	still	exist.	Further	research	examining	the	reasons	behind	variations	in	care	would	be	useful	in	
determining	where	to	focus	further	improvement	efforts.	Studies	are	needed	to	examine	potential	
challenges	in	individual	hospital	protocols	and	their	association	with	higher	or	lower	compliance	on	
individual	performance	measures.	Once	challenges	are	identified,	solutions	such	as	potential	penalties,	
incentives,	process	changes,	and	education	programs,	can	be	proposed.		
This	study	has	several	limitations.	First,	the	ACTION	Registry-GWTG	registry	is	voluntary,	and	thus,	
participating	hospitals	tend	to	be	larger,	tertiary	centers	that	may	have	better	baseline	performance.	
Therefore,	the	extent	of	the	variation	in	care	based	upon	these	characteristics	may	be	attenuated.	Next,	
the	study	period	for	this	analysis	was	limited	to	2010-2015.	Research	has	shown	that	duration	of	time	in	
quality	improvement	programs	is	associated	with	higher	rates	of	compliance	and	higher	quality	care	
[23].	Because	the	program	began	before	2010,	it	is	possible	that	time	in	the	program	differed	by	hospital	
as	some	may	have	joined	before	the	start	of	our	study	period.	This	also	may	have	influenced	the	effects	
seen	in	the	analysis.		Additionally,	there	is	a	possibility	that	contraindications	to	specific	elements	are	
not	captured	in	the	medical	record.	
CONCLUSIONS	
This	study	evaluated	the	degree	to	which	hospital	performance	varied	on	the	“all-or-none”	
defect-free	composite	measure	in	order	to	identify	hospital	characteristics	that	were	predictive	of	
higher	rates	of	defect-free	care	and	provide	insight	into	successful	processes	of	care.	Overall,	the	
analyses	determined	that	use	of	defect-free	care	was	significantly	associated	with	the	hospital’s	region	
of	the	US,	community	location	(urban,	rural,	or	suburban)	and	teaching	status.	These	findings	suggest	
that	institutions	within	the	aforementioned	categories	face	unique	challenges.		Understanding	the	
reasons	for	differences	among	hospitals	in	each	category	warrants	further	investigation.	
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APPENDIX
	
Measure	Name Measure	Description
Performance	measures
1.	Aspirin	at	arrival AMI	patients	who	received	aspirin	within	24	h	before	or	after	hospital	arrival
2.	Aspirin	prescribed	at	discharge AMI	patients	who	are	prescribed	aspirin	at	hospital	discharge
3.	Beta-blocker	prescribed	at	discharge AMI	patients	who	are	prescribed	a	beta-blocker	at	hospital	discharge
4.	Statin	at	discharge AMI	patients	who	are	prescribed	a	statin	at	hospital	discharge
5.	Evaluation	of	LVSF†
AMI	patients	with	documentation	in	the	hospital	record	that	LVSF	was	evaluated	during	
hospitalization	or	is	planned	after	discharge
6.	ACEI	or	ARB	for	LVSD
AMI	patients	with	LVSD	who	are	prescribed	an	ACEI	or	ARB	at	hospital	discharge	(for	purposes	
of	this	measure,	LVSD	is	defined	as	chart	documentation	of	an	LVEF	less	than	40%	or	a	
narrative	description	of	LVSF	consistent	with	moderate	or	severe	systolic	dysfunction)
7.	Time	to	fibrinolytic	therapy
Median	time	from	hospital	arrival	to	administration	of	fibrinolytic	therapy	in	AMI	patients	
with	ST-segment	elevation	or	LBBB	on	the	ECG	performed	closest	to	hospital	arrival	time;	AMI	
patients	with	ST-segment	elevation	or	LBBB	on	the	ECG	closest	to	hospital	arrival	time	
receiving	fibrinolytic	therapy	during	the	hospital	stay	with	a	time	from	hospital	arrival	to	
fibrinolysis	of	30	min	or	less
8.	Time	to	PCI
Median	time	from	hospital	arrival	to	primary	PCI	in	AMI	patients	with	ST-segment	elevation	
or	LBBB	on	the	ECG	performed	closest	to	arrival	time;	AMI	patients	with	ST-segment	
elevation	or	LBBB	on	the	ECG	closest	to	hospital	arrival	time	receiving	primary	PCI	during	the	
hospital	stay	with	a	time	from	hospital	arrival	to	PCI	of	90	min	or	less
9.	Reperfusion	therapy
AMI	patients	with	ST-segment	elevation	or	LBBB	on	the	ECG	performed	closest	to	arrival	
receiving	either	fibrinolysis	or	primary	PCI	or	who	are	transferred	to	another	facility	for	
primary	PCI
10.	Time	from	ED	arrival	at	STEMI	referral	facility	to	ED	
discharge	from	STEMI	referral	facility	in	patients	transferred	for	
primary	PCI†
Median	time	from	ED	arrival	at	STEMI	referral	facility	to	ED	discharge	from	STEMI	referral	
facility	for	AMI	patients	with	ST-segment	elevation	or	LBBB	on	the	ECG	performed	closest	to	
hospital	arrival	time	who	are	transferred	to	a	STEMI	receiving	facility	for	primary	PCI
11.	Time	from	ED	arrival	at	STEMI	referral	facility	to	primary	PCI	
at	STEMI	receiving	facility	among	transferred	patients†
Median	time	from	patient	arrival	at	a	STEMI	referral	facility's	ED	to	time	of	primary	PCI	at	a	
STEMI	receiving	facility	for	AMI	patients	presenting	with	ST-segment	elevation	or	LBBB	on	the	
ECG	performed	closest	to	first	hospital	arrival	time	who	are	transferred	to	a	STEMI	receiving	
facility	for	primary	PCI
12.	Adult	smoking	cessation	advice/counseling
AMI	patients	with	a	history	of	smoking	cigarettes	who	are	given	smoking	cessation	advice	or	
counseling	during	hospital	stay
13.	Cardiac	rehabilitation	patient	referral	from	an	inpatient	
setting†(6)
All	patients	hospitalized	with	a	primary	diagnosis	of	AMI	referred	to	an	early	outpatient	CR	
program
Test	measures
T-1.	LDL	cholesterol	assessment
AMI	patients	with	documentation	of	LDL	cholesterol	level	in	the	hospital	record	or	
documentation	that	LDL	cholesterol	testing	was	done	during	the	hospital	stay	or	is	planned	
after	discharge
T-2.	Excessive	initial	heparin	dose† AMI	patients	who	receive	excess	dosing	of	UFH	initially
T-3.	Excessive	initial	enoxaparin	dose† AMI	patients	who	receive	excess	dosing	of	subcutaneous	enoxaparin	initially
T-4.	Excessive	initial	abciximab	dose† AMI	patients	who	receive	excess	dosing	of	abciximab	initially
T-5.	Excessive	initial	eptifibatide	dose† AMI	patients	who	receive	excess	dosing	of	eptifibatide	initially
T-6.	Excessive	initial	tirofiban	dose† AMI	patients	who	receive	excess	dosing	of	tirofiban	initially
T-7.	Anticoagulant	dosing	protocol†
Presence	of	a	protocol	or	other	clinical	aid	(eg,	nomogram,	electronic	order	entry)	in	the	
hospital	record	of	AMI	patients	that	addresses	dosing	of	anticoagulant	therapy	and	
parenteral	antiplatelet	therapy	(ie,	UFH,	low-molecular-weight	heparin,	and	glycoprotein	
IIb/IIIa	inhibitors)
T-8.	Anticoagulant	error	tracking	system†
Evidence	of	a	tracking	system	for	identifying	dosing	errors	in	anticoagulation	therapy	in	the	
hospital	record	of	AMI	patients.
T-9.	Clopidogrel	prescribed	at	discharge	for	medically	treated	
AMI	patients†
Medically	treated	AMI	patients	who	are	prescribed	clopidogrel	or	ticlopidine	at	hospital	
discharge
Table	1:	ACC/AHA	STEMI/NSTEMI	Performance	Measures:	Inpatient	Measure	Descriptions
†New	measures.
Krumholz,	H.	M.,	Anderson,	J.	L.,	Bachelder,	B.	L.,	Fesmire,	F.	M.,	Fihn,	S.	D.,	Foody,	J.	M.,	...	&	Nallamothu,	B.	K.	(2008).	ACC/AHA	2008	performance	measures	
for	adults	with	ST-elevation	and	non–ST-elevation	myocardial	infarction:	a	report	of	the	American	College	of	Cardiology/American	Heart	Association	Task	
Force	on	Performance	Measures	(Writing	Committee	to	Develop	Performance	Measures	for	ST-Elevation	and	Non–ST-Elevation	Myocardial	Infarction)	
developed	in	collaboration	with	the	American	Academy	of	Family	Physicians	and	American	College	of	Emergency	Physicians	Endorsed	by	the	American	
Association	of	Cardiovascular	and	....	Journal	of	the	American	College	of	Cardiology ,	52 (24),	2046-2099.
LVEF	indicates	left	ventricular	ejection	fraction;	LBBB,	left	bundle-branch	block;	ECG,	electrocardiographic;	ED,	emergency	department;	CR,	cardiac	
rehabilitation/secondary	prevention;	and	UFH,	unfractionated	heparin.
Test	measures	have	been	designated	for	use	in	internal	quality	improvement	programs	only	and	are	not	appropriate	for	any	other	use,	eg,	pay	for	
performance,	physician	ranking,	or	public	reporting	programs.
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Category Example	Elements
Patient	demographics Age,	sex,	race,	insurance	s tatus
Medica l 	his tory	and	
risk	factors
Height,	weight,	hypertens ion,	diabetes 	
mel l i tus ,	dys l ipidemia,	periphera l 	
arteria l 	disease,	current	smoker,	prior	
cardiac	his tory,	prior	revascularization
Hospital	presentation
Transfer	s tatus ,	date/time	of	fi rs t	
medica l 	contact,	arriva l 	date/time,	
date/time	of	fi rs t	ECG,	location	of	
ini tia l 	eva luation
Ini tia l 	cardiac	s tatus
ECG	findings ,	heart	rate,	systol ic	blood	
pressure,	cardiogenic	shock,	heart	
fa i lure
Medications	and	
associated	doses
Antiplatelet	agents ,	warfarin,	
unfractionated	heparin,	low	molecular	
weight	heparin,	biva l i rudin,	
fondaparinux,	GP	IIb-IIIa 	inhibi tors ,	β-
blockers ,	ACE	inhibi tors ,	angiotens in	
receptor	blockers ,	a ldosterone	blocking	
agents ,	l ipid-lowering	agents
Reperfus ion	s trategy
Thrombolytic	date/time,	primary	PCI	
date/time,	rescue	PCI	date/time,	
nonsystems	reason	for	delay	in	
reperfus ion
Procedures
LVEF	assessment,	diagnostic	
catheterization,	PCI	(other	than	
primary),	CABG
Lab	va lues
Cardiac	markers ,	l ipid	panel ,	
creatinine,	hemoglobin,	hemoglobin	
A1C,	INR,	BNP
Outcomes
Death,	re-MI,	bleeding,	transfus ion,	
heart	fa i lure	cardiogenic	shock,	s troke
GP	indicates	glycoprotein;	ACE,	angiotensin-converting	enzyme;	PCI,	
percutaneous	coronary	intervention;	LVEF,	left	ventricular	ejection	
fraction;	CAGB,	coronary	artery	bypass	graft;	INR,	international	normalized	
ratio;	and	BNP,	b-type	natriuretic	peptide.
Table	2:	ACTION-GWTG	Data	Elements
Running	head:	HOSPITAL	VARIATION	IN	DEFECT	FREE	CARE	
	
21	
	
	
	
	
	
	
	
	
	
Performance	Indicator Definition
(1)	Aspirin	at	Arrival
AMI	patients 	who	received	aspirin	within	24	h	before	or	after	
hospita l 	arriva l
(2)	Aspirin	prescribed	at	Discharge AMI	patients 	who	are	prescribed	aspirin	at	hospita l 	discharge
(3)	Beta-Blocker	Prescribed	at	Discharge
AMI	patients 	who	are	prescribed	a 	beta-blocker	at	hospita l 	
discharge
(4)	Statin	Prescribed	at	Discharge AMI	patients 	who	are	prescribed	a 	s tatin	at	hospita l 	discharge
(5)	Evaluation	of	LV	Systol ic	Function
AMI	patients 	with	documentation	in	the	hospita l 	record	that	LVSF	
was 	evaluated	during	hospita l i zation	or	i s 	planned	after	discharge
(6)	ACEI	or	ARB	for	LVSD	at	Discharge
AMI	patients 	with	LVSD	who	are	prescribed	an	ACEI	or	ARB	at	
hospita l 	discharge	(for	purposes 	of	this 	measure,	LVSD	is 	defined	
as 	chart	documentation	of	an	LVEF	less 	than	40%	or	a 	narrative	
description	of	LVSF	cons is tent	with	moderate	or	severe	systol ic	
dysfunction)
(7)	Time	to	Fibrinolytic	Therapy
Median	time	from	hospita l 	arriva l 	to	adminis tration	of	fibrinolytic	
therapy	in	AMI	patients 	with	ST-segment	elevation	or	LBBB	on	the	
ECG	performed	closest	to	hospita l 	arriva l 	time;	AMI	patients 	with	ST-
segment	elevation	or	LBBB	on	the	ECG	closest	to	hospita l 	arriva l 	
time	receiving	fibrinolytic	therapy	during	the	hospita l 	s tay	with	a 	
time	from	hospita l 	arriva l 	to	fibrinolys is 	of	30	min	or	less
(8)	Time	to	Primary	PCI
Median	time	from	hospita l 	arriva l 	to	primary	PCI	in	AMI	patients 	
with	ST-segment	elevation	or	LBBB	on	the	ECG	performed	closest	to	
arriva l 	time;	AMI	patients 	with	ST-segment	elevation	or	LBBB	on	the	
ECG	closest	to	hospita l 	arriva l 	time	receiving	primary	PCI	during	the	
hospita l 	s tay	with	a 	time	from	hospita l 	arriva l 	to	PCI	of	90	min	or	
less
(9)	Reperfus ion	Therapy
AMI	patients 	with	ST-segment	elevation	or	LBBB	on	the	ECG	
performed	closest	to	arriva l 	receiving	ei ther	fibrinolys is 	or	primary	
PCI	or	who	are	transferred	to	another	faci l i ty	for	primary	PCI
(10)	Adult	Smoking	Cessation	Advice	Counsel ing
AMI	patients 	with	a 	his tory	of	smoking	cigarettes 	who	are	given	
smoking	cessation	advice	or	counsel ing	during	hospita l 	s tay
(11)	Cardiac	Rehabi l i tation	Patient	Referra l 	From	an	Inpatient	Setting Al l 	patients 	hospita l i zed	with	a 	primary	diagnos is 	of	AMI	referred	
to	an	early	outpatient	CR	program
Table	3:	NCDR	AR-G	"All-or-None"	Defect-Free	Composite	Measure	Components	
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Table	4:	Selected	Patient	Characteristics	by	Hospital	Characteristic
N 105724 44787 25672 191271
Demographics
Age	(y):	 64.00	(55.00,	75.00)	 65.00	(56.00,	75.00) 65.00	(55.00,	77.00) 63.00	(54.00,	73.00)
Age	Groups
Age<55 24.92 22.16 23.17 26.74
Age	55	to	<64 26.57 27.47 25.44 27.42
Age	65	to	<74 22.63 24.15 22.04 23.62
Age>=75 25.88 26.21 29.35 22.21
Female 34.79 32.27 36.95 34.41
Race
Hispanic 2.84 9.55 3.81 4.64
White	non-hispanic 89.57 89.31 90.32 80.38
Black	non-Hispanic 8.24 3.66 6.85 16.94
Other 1.86 5.29 2.26 2.11
Insurance
Medicare 49.47 48.12 50.76 49.94
Medicaid	or	not	private 14.27 19.04 10.97 14.61
Private 62.57 57.19 72.26 53.33
None 10.47 9.84 4.89 13.78
Clinical	features	on	presentation
Heart	Rate	(beat/min) 82.00	(69.00,	97.00) 80.00	(68.00,	95.00) 82.00	(70.00,	97.00) 82.00	(69.00,	97.00)
Systolic	Blood	Pressure	(mm	Hg) 147.00	(126.00,	168.00) 144.00	(124.00,	165.00) 145.00	(125.00,	166.00) 146.00	(126.00,	168.00)
STEMI 36.52 39.72 37.86 39.4
Cardiogenic	Shock	 3.36 4.32 2.91 3.51
History	and	Risk	Factors
BMI 29.00	(25.50,	33.40) 28.10	(24.80,	32.20) 28.40	(25.10,	36.20) 28.50	(25.10,	32.80)
Current/Recent	Smoker	(w/in	1	year) 35.94 29.73 30.25 36.77
Hypertension 73.35 70.27 72.87 75.41
Dyslipidemia 60.66 57.88 60.72 60.06
Currently	on	Dialysis 2.36 2.27 1.97 2.55
Chronic	Lung	Disease 15.03 11.96 11.22 13.89
Diabetes	Mellitus 32.32 30.58 30.88 34.44
Prior	CAD 36.14 32.48 32.46 37.86
Prior	MI 24.18 22.59 21.49 25.81
Prior	PCI 25.04 21.69 20.92 25.53
Prior	CABG 13.63 10.93 12.59 14.06
Prior	Heart	Failure 11.84 9.99 9.88 12.27
Atrial	Fibrillation	or	Flutter	Past	2	Weeks 6.77 6.91 7.48 6.65
Cerebrovascular	Disease 12.25 10.94 10.43 12.27
Prior	Stroke 7.46 6.83 6.41 8.16
Peripheral	Arterial	Disease 10.34 8.18 8.13 9.65
Lab	values	on	presentation
Troponin	Ratio 2.00	(0.43,	12.38) 2.33	(0.47,	14.25) 3.27	(0.67,	20.00) 2.00	(0.500,	13.14)
CKMB	Ratio 1.05	(0.45,	3.675 1.21	(0.49,	4.84) 1.32	(0.55,	4.86) 1.16	(0.48,	4.24)
Creatinine	(mg/dL) 1.00	(0.90,	1.30) 1.00	(0.90,	1.30) 1.00	(0.80,	1.30) 1.00	(0.90,	1.30)
Creatinine	Clearance 81.20	(54.22,	111.65) 79.42	(53.91,	107.78) 80.95	(52.76,	112.38) 81.92	(55.39,	111.61)
Hemoglobin	(g/dL) 14.1	(12.6,	15.3) 14.30	(12.90,	15.60) 13.90	(12.50,	15.20) 14.00	(12.50,	15.20)
Hemoglobin	A1c 6.20	(5.70,	7.50) 6.10	(5.60,	7.40) 6.00	(5.60,	7.10) 6.10	(5.60,	7.50)
INR 1.00	(1.00,	1.10) 1.00	(1.00,	1.10) 1.00	(1.00,	1.10) 1.00	(1.00,	1.10)
Total	Cholesterol	(mg/dL) 164.00	(135.00,	195.00) 162.00	(134.00,	195.00) 164.00	(136.00,	196.00) 165.00	(136.00,	197.00)
HDL	Cholesterol	(mg/dL) 38.00	(31.00,	46.00) 38.00	(31.00,	46.00) 40.00	(33.00,	49.00) 37.00	(30.00,	46.00)
LDL	Cholesterol	(mg/dL) 95.00	(70.00,	123.00) 94.00	(69.00,	122.00) 94.00	(69.00,	122.00) 97.00	(72.00,	125.00)
Triglycerides	(mg/dL) 123.00	(85.00,	183.00) 122.00	(84.00,	182.00) 119.00	(83.00,	175.00) 124.00	(84.00,	186.00)
Lipid	Panel	Values	Out	of	Range 6.45 4.89 4.69 7.3
BNP	(pg/mL) 213.00	(60.00,	627.00) 236.00	(71.00,	622.00) 297.00	(84.00,	811.00) 203.00	(58.00,	599.00)
NT-proBNP	(pg/mL) 1255.00	(253.00,	4463.00)1165.50	(220.00,	4422.00)1019.00	(214.00,	3699.00)1200.00	(247.00,	4610.00)
**Continuous	variables	are	presentes	as	Median	(Q1,	Q3)
*Categorical	variables	are	presented	as	percentages
Description
Region	of	the	US
Midwest West Northeast South
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Table	4:	Selected	Patient	Characteristics	by	Hospital	Characteristic	(con't)
N 212246 51292 103916 176975 190479
Demographics
Age	(y):	 63.00	(54.00,	74.00) 64.00	(54.00,	74.00) 64.00	(55.00,	75.00) 64.00	(55.00,	74.00) 63.00	(54.00,	74.00)
Age	Groups
Age<55 26.16 25.04 24.07 25.98 24.80
Age	55	to	<64 27.6 26.82 26 27.51 26.53
Age	65	to	<75 23.13 24.05 23.23 22.93 23.67
Age>=75 23.1 24.08 26.69 23.57 24.99
Female 34.12 34.51 34.91 34.32 34.48
Race
Hispanic 5.02 2.51 4.98 3.97 5.41
White	non-hispanic 83.56 89.55 85.02 82.64 87.14
Black	non-Hispanic 13.61 8.51 10.84 14.42 9.63
Other 2.13 1.73 3.41 2.27 2.62
Insurance
Medicare 49.25 52.67 48.18 49.64 49.64
Medicaid	or	not	private 16.51 17.14 10.19 16.03 13.48
Private 55.76 54.47 64.03 57.59 57.98
None 12.00 12.36 10.86 11.78 11.67
Clinical	features	on	presentation
Heart	Rate	(beat/min) 81.00	(69.00,	96.00) 82.00	(69.00,	97.00) 82.00	(69.00,	97.00) 82.00	(69.00,	97.00) 82.00	(69.00,	96.00)
Systolic	Blood	Pressure	(mm	Hg) 146.00	(125.00,	167.00) 146.00	(126.00,	168.00) 147.00	(126.00,	168.00) 146.00	(126.00,	168.00) 146.00	(125.00,	167.00)
STEMI 39.91 35.86 36.94 38.17 38.86
Cardiogenic	Shock	 3.65 3.38 3.33 3.34 3.72
History	and	Risk	Factors
BMI 28.70	(25.10,	33.00) 28.70	(25.20,	33.00) 28.40	(25.10,	32.70) 28.50	(25.10,	32.90) 28.7	(25.10,	32.90)
Current/Recent	Smoker	(w/in	1	year) 36.64 37.75 31.06 35.98 34.40
Hypertension 73.94 74.93 73.72 74.83 73.14
Dyslipidemia 58.78 62.63 61.24 61.73 58.17
Currently	on	Dialysis 2.48 2.08 2.46 2.45 2.38
Chronic	Lung	Disease 13.61 16.71 12.74 13.27 14.04
Diabetes	Mellitus 33.37 33.72 32.28 33.4 32.80
Prior	CAD 36.18 38.42 35.62 36.77 35.86
Prior	MI 24.95 25.83 23.45 25.55 23.68
Prior	PCI 24.59 25.83 24 24.66 24.54
Prior	CABG 12.99 15.29 13.47 13.6 13.29
Prior	Heart	Failure 11.55 12.66 11.53 12.38 10.97
Atrial	Fibrillation	or	Flutter	Past	2	Weeks 6.42 6.9 7.43 6.75 6.80
Cerebrovascular	Disease 12.09 12.36 11.54 12.43 11.48
Prior	Stroke 7.68 7.97 7.52 7.88 7.46
Peripheral	Arterial	Disease 9.51 10.01 9.45 9.98 9.12
Lab	values	on	presentation
Troponin	Ratio 2.20	(0.50,	14.33) 2.00	(0.50,	11.20) 2.07	(0.50,	13.15) 1.75	(0.40,	10.60) 2.56	(0.56,	16.56)
CKMB	Ratio 1319	(0.50,	4.49) 1.03	(0.45,	3.39) 1.13	(0.47,	4.06) 1.12	(0.48,	3.89) 1.18	(0.48,	4.47)
Creatinine	(mg/dL) 1.00	(0.90,	1.30) 1.00	(0.90,	1.30) 1.10	(0.90,	1.30) 1.00	(0.90,	1.30) 1.00	(0.80,	1.30
Creatinine	Clearance 82.56	(55.71,	112.47) 81.24	(55.03,	115.51) 79.01	(52.48,	108.55) 80.21	(54.06,	109.86) 82.39	(55.27,	112.45)
Hemoglobin	(g/dL) 14.10	(12.60,	15.30) 14.10	(12.60,	15.30) 14.00	(12.60,	15.30) 14.10	(12.60,	15.30) 14.00	(12.50,	15.30)
Hemoglobin	A1c 6.10	(5.60,	7.50) 6.20	(5.70,	7.50) 6.10	(5.60,	7.50) 6.20	(5.70,	7.60) 6.10	(5.60,	7.40)
INR 1.00	(1.00,	1.10) 1.00	(1.00,	1.10) 1.00	(1.00,	1.10) 1.00	(1.00,	1.10) 1.00	(1.00,	1.10)
Total	Cholesterol	(mg/dL) 164.00	(136.00,	196.00) 165.00	(137.00,	197.00) 163.00	(135.00,	195.00) 164.00	(136.00,	195.00) 165.00	(136.00,	196.00)
HDL	Cholesterol	(mg/dL) 37.00	(31.00,	46.00) 37.00	(31.00,	45.00) 38.00	(31.00,	47.00) 37.00	(31.00,	46.00) 38.00	(31.00,	46.00)
LDL	Cholesterol	(mg/dL) 96.00	(71.00,	124.00) 96.00	(71.00,	124.00) 95.00	(70.00,	123.00) 95.00	(71.00,	123.00) 96.00	(71.00,	124.00)
Triglycerides	(mg/dL) 123.00	(85.00,	184.00) 126.00	(87.00,	190.00) 121.00	(83.00,	180.00) 124.00	(85.00,	185.00) 122.00	(84.00,	182.00)
Lipid	Panel	Values	Out	of	Range 6.40 6.55 6.96 7.24 5.87
BNP	(pg/mL) 215.00	(62.00,	613.00) 208.00	(62.00,	605.00) 219.00	(60.00,	647.00) 216.00	(60.00,	621.00) 214.00	(63.00,	623.00)
NT-proBNP	(pg/mL) 1291.00	(258.00,	4739.00) 1243.00	(266.00,	4800.00) 1045.00	(211.00,	3970.00) 1086.00	(220.00,	4249.50) 1316.50	(270.00,	4762.00)
*Categorical	variables	are	presented	as	percentages
**Continuous	variables	are	presentes	as	Median	(Q1,	Q3)
Community	Location Teaching	Status
Description Urban Rural Suburban Teaching Non-Teaching
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Table	5:	Selected	Hospital	Characteristics
Hospital	Characteristic
ALL 270
Total	beds: 1200	(700,	2031)
Hospital	Bed	Size
0-258 83
259-389 72
390-572 64
573-2000 51
Annual	Number	of	PCIs
0-357 90
358-675 73
676-1129 62
1130-4722 45
Annual	Number	of	Cardiac	Caths
0-850 87
851-1499 79
1500-2562 55
2563-13500 47
Percentage	of	Medicare	Patients
0-42% 62
43-52% 73
53-60% 48
61-100% 87
Hospital	Type
Government 5
Community 236
University 29
Public/Private
Public 156
Private 114
Region
Northeast 16
Midwest 83
South 133
West 38
Teaching	status
Non-Teaching 154
Teaching 116
Community	Location
Rural 43
Urban 147
Suburban 80
*Category	sums	may	not	equal	the	total	hospital	number	due	to	
unknowns	values
**Categorical	variables	are	presented	as	percentages
***Continuous	variables	are	presentes	as	Median	(Q1,	Q3)
